(Q35174901)

6 August 2017

Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice (English)

1 reference

6 August 2017

1 reference

Daniel Engelbertsen

1

0 references

Harry Björkbacka

object named as

Harry Björkbacka

4

0 references

author name string

Sara Rattik

2

1 reference

6 August 2017

Anki Knutsson

3

1 reference

6 August 2017

Eva Bengtsson

5

1 reference

6 August 2017

Jan Nilsson

6

1 reference

6 August 2017

27 May 2014

1 reference

6 August 2017

Cardiovascular Research

1 reference

6 August 2017

103

1 reference

6 August 2017

2

1 reference

6 August 2017

304-312

1 reference

The immune system in atherosclerosis

6 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Adaptive immunity in atherogenesis: new insights and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Autoimmunity in atherosclerosis: a protective response losing control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Pathophysiology of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

T-cell costimulation and coinhibition in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Cytokines in atherosclerosis: pathogenic and regulatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Low density lipoprotein undergoes oxidative modification in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Primary antitumor immune response mediated by CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Protective Role of Interleukin-10 in Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU131

21 January 2018

Identifiers

DOI

10.1093/CVR/CVU131

1 reference

6 August 2017

1 reference